Sunday, November 10
|
Session Title |
Speaker(s) |
Primary Track |
Presentation Format |
6:30 AM - 7:55 AM
|
Pediatric Asthma: Where Are We Going? (Breakfast Symposium)
Supported by an independent educational grant from GlaxoSmithKline
Pediatric asthma is one of the most common chronic diseases in children. There is a continued need to understand best practices to improve the care of these children. Understanding how the environment plays a role in pediatric asthma is key in providing better control for our patients. How does climate change affect pediatric asthma? How can we improve the indoor environment to decrease flare-ups of pediatric asthma? Biologics are playing a major role in severe asthma in adults, but where do they play a role in children with asthma? What are the benefits and risks for the pediatric population? What are the new biologics we may see in children? With the Asthma Controller Step Down Yardstick in Pediatric Asthma, how does an allergist decrease medications in asthma in the pediatric population? When is it safe to decrease controller treatments, and how do you monitor the child after you decrease it?
Moderators: William C. Anderson, MD, FACAAI, and Alan Goldsobel, MD, FACAAI
6:30 am
Welcome and Introductions
William C. Anderson, MD, FACAAI
Alan Goldsobel, MD, FACAAI
6:35 am
The Environment and Pediatric Asthmaa
Jonathan Corren, MD, FACAAI
7:00 am
Current and Future Biologics in Pediatric Asthma
Leonard Bacharier, MD, FACAAI
7:25 am
How to Apply Asthma Controller Step Down Yardstick in Pediatric Asthma
Matthew Rank, MD, FACAAI
7:45 am
Questions and Discussion
|
|
Moderator:
William C. Anderson, MD
Moderator:
Alan B. Goldsobel, MD, FACAAI
Speaker:
Jonathan Corren, MD, FACAAI
Speaker:
Leonard Benjamin Bacharier, MD
Speaker:
Matthew Rank, MD, FACAAI
|
Asthma and Respiratory / Sleep Disorders
|
Symposium
|
8:00 AM - 9:30 AM
|
Modifying Our Approach
MOC/CME
The advent of targeted therapies and further understanding of the microbiome offer exciting opportunities for new approaches to patients with asthma and allergic conditions. However, knowledge gaps continue to exist. This session will review what we've learned, what we have yet to learn and, most importantly, what can be implemented now.
Moderator: Mark L. Corbett, MD, FACAAI
8:00 am
Welcome and Introductions
Mark L. Corbett, MD, FACAAI
8:05 am
Making Sense of New Approaches to Asthma Therapy
Paul O'Byrne, MD
8:25 am
Risk Factors for Developing Allergic Disease: Lessons From the Isle of Wright
Syed H. Arshad, MBBS, DM
8:45 am – John P. McGovern Lecture
Rewilding the Microbiome: The Importance of Ecological Approaches to Immune Health
Susan Prescott, MD, MBBS, PhD
9:05 am
Manipulating the Microbiome to Prevent or Treat Allergic Conditions
Carina Venter, PhD, RD
|
|
Moderator:
Mark L. Corbett, MD, FACAAI
Speaker:
Paul O'Byrne, MD
Speaker:
Syed H. Arshad, MBBS, DM
Speaker:
Susan Prescott, MD, PhD
Speaker:
Carina Venter, PhD, RD
|
Asthma and Respiratory / Sleep Disorders
|
Plenary Session
|
9:00 AM - 1:30 PM
|
Exhibit Hall Open
|
|
|
|
College Resource Center Open in Exhibit Hall
|
|
|
|
9:30 AM - 10:00 AM
|
E-posters – Meet the Authors: Session 4
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
Not For Credit |
|
Moderator:
Brian T. Kelly, MD, MA
|
|
|
Refreshment Break in Exhibit Hall
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. |
|
|
|
|
9:35 AM - 10:00 AM
|
Product Theater 1: Steroid-Free EUCRISA: A Treatment Option for Mild-to-Moderate Atopic Dermatitis in Patients 2 Years and Older
Supported by Pfizer, Inc.
Not For Credit
Presented by:
Ankmalika Gupta, MD
Join us for an interactive presentation on a steroid-free topical therapy for the treatment of mild-to-moderate atopic dermatitis. Expert faculty will guide the audience through an in-depth look into the product and answer questions to help attendees gain a better understanding of this treatment option.
Also visit Pfizer, Inc. at Booth #1013. |
|
|
|
|
10:00 AM - 11:30 AM
|
7 for 11: Hot Topics in Pediatric A/I – A Joint Presentation from AAP-SOAI & ACAAI
Each of the 7 presenters will have only 11 minutes to deliver insightful, targeted and dynamic information on their assigned topics.
Moderators: Todd A. Mahr, MD, FACAAI
10:00 am
Welcome and Introductions
Todd A. Mahr, MD, FACAAI
10:05 am
Asthma
Angela D. Hogan, MD, FACAAI
10:16 am
Food Allergy – Non-Treatment
J. Wesley, Sublett, MD, MPH, FACAAI
10:27 am
Food Allergy – Treatment
J. Andrew Bird, MD, FACAAI
10:38 am
Biologics
Carla M. Davis, MD, FACAAI
10:49 am
Anaphylaxis
Julie Wang, MD, FACAAI
11:00 am
Immunology
Mary Beth Fasano, MD, MSPH, FACAAI
11:11 am
Epidemiology
Ruchi Gupta, MD, MPH
11:22 am
Questions and Discussion
|
|
Moderator:
Todd A. Mahr, MD, FACAAI
Speaker:
Angela D. Hogan, MD, FACAAI
Speaker:
J. Wesley Sublett, MD, MPH, FACAAI
Speaker:
J. Andrew Bird, MD, FACAAI
Speaker:
Carla M. Davis, MD, FACAAI
Speaker:
Julie Wang, MD, FACAAI
Speaker:
Mary B. Fasano, MD, MSPH, FACAAI
Speaker:
Ruchi Gupta, MD, MPH
|
|
Symposium
|
Primary Immune Deficiency: Optimal Care for Optimal Outcomes
Supported by an independent educational grant from CSL Behring
This session will help participants recognize the key features that impact the disease burden and outcomes for patients with primary immune deficiencies. Early recognition of these issues can help to reduce their impact on patient’s wellbeing and, by reducing disease related morbidity, improve patient outcomes.
Moderators: Purvi S. Parikh, MD, and Kenneth Paris, MD, MPH
10:00 am
Welcome and Introductions
Purvi S. Parikh, MD
Kenneth Paris, MD, MPH
10:05 am
Patient-centered Outcomes
Mark M. Ballow, MD, FACAAI
10:30 am
Medical Knowledge of Complications of Primary Immune Deficiencies
Kenneth Paris, MD, MPH
10:55 am
Communication With Patients
Richard L. Wasserman, MD, PhD, FACAAI
11:20 am
Questions and Discussion
|
|
Moderator:
Purvi S. Parikh, MD
Moderator:
Kenneth Paris, MD, MPH
Speaker:
Mark M. Ballow, MD, FACAAI
Speaker:
Kenneth Paris, MD, MPH
Speaker:
Richard L. Wasserman, MD, PhD, FACAAI
|
Clinical Immunology and Autoimmune and Biologicals
|
Symposium
|
USP 797, The Final Word – What Does It Say? What Does It Mean? What Do I Have to Do?
MOC/CME
Any allergist that mixes allergy vaccines should be following the guidance of USP 797. Recent issues, unrelated to allergy vaccine preparation, have caused the USP to alter its requirements for drug compounding. Though initially allergy mixing seemed as though it might be consumed by the “compounding” controversy, the ACAAI and others worked to demonstrate the differences between mixing allergy vaccines in an allergist’s office and the compounding of pharmaceuticals by commercial compounding companies. Although the efforts of the ACAAI Advocacy Council and others were largely successful, changes to the USP 797 requirements for the mixing of allergy vaccines did occur. This symposium will review the history of the issue, address the changes and suggest operational recommendations for implementation of these changes.
Moderators: Richard G. Gower, MD, FACAAI, and Erika Gonzalez-Reyes, MD, FACAAI
10:00 am
Welcome and Introductions
Richard G. Gower, MD, FACAAI
Erika Gonzalez-Reyes, MD, FACAAI
10:05 am
The History of USP 797 Guidance and Regulation
James L. Sublett, MD, FACAAI
10:30 am
A Review of Changes
James M Tracy, DO, FACAAI
10:55 am
Recommendations for Operationalizing the Change in Mixing
J. Allen Meadows, MD, FACAAI
11:20 am
Questions and Discussion
|
|
Moderator:
Richard G. Gower, MD, FACAAI
Moderator:
Erika Gonzalez Reyes, MD, FACAAI
Speaker:
James L. Sublett, MD, FACAAI
Speaker:
James M. Tracy, DO, FACAAI
Speaker:
J. Allen Meadows, MD, FACAAI
|
Immunotherapy and Diagnostics
|
Symposium
|
11:30 AM - 1:00 PM
|
E-posters – Meet the Authors: Session 5
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
Not For Credit |
|
Moderator:
Brian T. Kelly, MD, MA
|
|
|
Visit Exhibits / Lunch on Own
|
|
|
|
Women in Allergy Luncheon
Registration required.
Supported by Genentech and Novartis Pharmaceuticals Corporation
Not For Credit |
|
|
|
|
11:35 AM - 1:00 PM
|
Product Theater 1: Principles of Severe Eosinophilic Asthma
Supported by AstraZeneca
Not For Credit
Presented by:
Reynold A Panettieri, MD
Join us for an educational program exploring the mechanistic role of eosinophils in severe asthma. This interactive presentation will review updated guidance in assessing severe asthma, examine the role of eosinophils in severe asthma, and highlight the impact of oral corticosteroid (OCS) use in severe uncontrolled asthma.
Also visit AstraZeneca at Booth #301. |
|
|
|
|
Product Theater 2: A presentation on DUPIXENT ® (dupilumab)
Not For Credit
Presented by:
Jonathan A. Bernstein, MD
Lawrence D. Sher, MD
Come learn about clinical efficacy, safety information, MOA, and dosing and administration, and how DUPIXENT may help your patients.
Also visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. at Booth #313. |
|
|
|
|
Product Theater 3: Evolving Understanding of Inflammatory Mediators in Asthma
Supported by Novartis Pharmaceuticals Corporation
Not For Credit
Presented by:
Bradley E. Chipps, MD
In this presentation, Dr. Bradley Chipps will discuss the multiple pro-inflammatory pathways involved in asthma pathophysiology, reviewing established mediators such as IgE, IL-4/IL-13 and IL-5, as well as covering new science surrounding DP2 as a major regulator of the inflammatory cascade. The presentation will also explore the impact of persistent inflammation on downstream structural effects and, ultimately, clinical manifestations of asthma that remain poorly controlled in many patients.
Also visit Novartis Pharmaceuticals Corporation at Booth #1003. |
|
|
|
|
1:00 PM - 2:30 PM
|
Oral Abstracts Session 1A: Adverse Drug Reactions, Insect Reactions, Anaphylaxis
Moderators: Kevin Kelly, MD, FACAAI, and Stephanie Mawhirt, DO
1:00 pm
Welcome and Introductions
Kevin Kelly, MD, FACAAI
Stephanie Mawhirt, DO
1:00 pm
A001 – A Retrospective Analysis of Penicillin Allergy Relabeling During Readmission After Negative Inpatient Penicillin Allergy Testing
Matthew R. Norris, MD
1:15 pm
A002 – Impact of Educational Lecture on Physician Barriers to Recognition and Management of Anaphylaxis
Ashley Ciliberti, MD
1:30 pm
A003 – Direct Amoxicillin Challenge Without Preliminary Skin Testing for Pediatric Patients With Low-risk Penicillin Allergy Symptoms
Laura A. Wang, MD, MPH
1:45 pm
A004 – Trends in Anaphylaxis in Young Children in the United States from 2006-2015
Lacey B. Robinson, MD
2:00 pm
A005 – Erythema Multiforme-like Rashes: Are They Truly Antibiotic-associated?
Katharine M. Guarnieri, MD
2:15 pm
A006 – Adverse Drug Reactions in Cystic Fibrosis Patients: Using Data to Develop an Antibiotic Evaluation Program
Karen M. Anstey, MD
|
|
Moderator:
Kevin Joseph Kelly, MD
Moderator:
Stephanie Mawhirt, DO
|
|
Oral Abstract
|
Oral Abstracts Session 1B: Allergy Diagnostics and Immunotherapy and Clinical Immunology, Immunodeficiency, Food Allergy
Moderators: Mitchell Grayson, MD, FACAAI, and Michelle Maciag, MD
1:00 pm
Welcome and Introductions
Mitchell Grayson, MD, FACAAI
Michelle Maciag, MD
1:00 pm – Clemens von Pirquet Award – Third Place
A100 – Long-term Adherence to Imported Fire Ant Subcutaneous Immunotherapy
Brittanie I. Neaves, MD
1:15 pm
A101 – Analysis of Allergen-specific IgE Cut Points to Cat, Dog, and Grass in Children
Bradley M. Boelkins, MD
1:30 pm
A102 – Imported Fire Ant Immunotherapy Prescribing Patterns in a Large Health Care System
Robert H. Wauters, MD
1:45 pm
A250 – Humoral Immunodeficiency in Patients With Chronic Lymphocytic Leukemia
S. Shahzad Mustafa, MD, FACAAI
2:00 pm
A251 – Reconstitution of IgG Subclasses Following Immunoglobulin Administration in Adults With Common Variable Immune Deficiency
David J. Reeder, MD
2:15 pm
A300 – Elevated Allergic Comorbidity in Patients With Food Protein-induced Enterocolitis
Melanie Ruffner, MD, PhD
|
|
Moderator:
Mitchell H. Grayson, MD, FACAAI
Moderator:
Michelle Maciag, MD
|
|
Oral Abstract
|
Oral Abstracts Session 1C: Adverse Drug Reactions, Insect Reactions, Anaphylaxis, Asthma, Other Lower Airway Disorders, Other
Moderators: Peck Ong, MD, FACAAI, and Peter Capucilli, MD
1:00 pm
Welcome and Introductions
Peck Ong, MD, FACAAI
Peter Capucilli, MD
1:00 pm
A107 – Impact of Penicillin Allergy Label in Liver Transplant Recipients During Transplant Hospitalization
Gabriel Motoa, MD
1:15 pm
A200 – Asthma Population Management in the Children’s Hospital Emergency Department
Claire Atkinson, MD
1:30 pm
A201 – Influence of Natural Lung Surfactant Inhalation on Symptoms and Lung Function in Severe Bronchial Asthma
Lawrence M. DuBuske, MD, FACAAI
1:45 pm
A202 – Lack of Concordance Between FeNO and Spirometry in Patients With Chronic Cough
Talal M. Nsouli, MD, FACAAI
2:00 pm
A350 – Telemedicine and Patient Satisfaction in Allergy and Immunology
Jay M. Portnoy, MD, FACAAI
|
|
Moderator:
Peck Y Ong, MD
Moderator:
Peter Capucilli, MD
Presenting Author:
Gabriel Motoa, M.D.
Presenting Author:
Claire Atkinson, MD
Presenting Author:
Lawrence M. DuBuske, MD, FACAAI
Presenting Author:
Talal M Nsouli, MD
Presenting Author:
Jay M. Portnoy, MD, FACAAI
|
|
Oral Abstract
|
Filling the Gaps – The Allergist's Role in Coordinating Care Across Age Groups
Transition is challenging for anyone, and different ages present different needs. This session will review unique aspects affecting children, adolescents and elderly patients who have asthma, food allergies and other allergic conditions. From discussion with caregivers to practical tips to help prepare for self-management, this session will provide an overview and a blueprint that attendees can immediately apply to patient care.
Moderators: Dana V. Wallace, MD, FACAAI, and Kelly M. Maples, MD, FACAAI
1:00 pm
Welcome and Introductions
Dana V. Wallace, MD, FACAAI
Kelly M. Maples, MD, FACAAI
1:05 pm
The Parent Is the Teacher: How to Help Parents Prepare for Transitioning Their Child to School
Ruchi Gupta, MD, MPH
1:30 pm
You’re on Your Own: How to Help Adolescents Prepare for Self-management and Independent Living
William C. Anderson, MD, FACAAI
1:55 pm
Helping Our Elderly Patients: Unique Aspects of Their Care
Mervat Nassef, MD, FACAAI
2:20 pm
Questions and Discussion
|
|
Moderator:
Dana V. Wallace, MD, FACAAI
Moderator:
Kelly M. Maples, MD, FACAAI
Speaker:
Ruchi Gupta, MD, MPH
Speaker:
William C. Anderson, MD
Speaker:
Mervat Nassef, MD, FACAAI
|
Population Health and Infectious Diseases / International Travel
|
Practical Applications at Work Seminar
|
PBL – An Older Adult Patient With Difficult-to-control Asthma: Learning to Care for the Older Adult Patient Using SDM
Limit 40. Seats available on first-come, first-served basis.
Supported by an independent educational grant from GlaxoSmithKline
An interactive PBL presentation of an older asthmatic patient with poor adherence to asthma medication and inadequate communication will be presented. These are critical problems in asthma care in the older patient because they contribute to morbidity and mortality through poor control, frequent asthma exacerbations, acute care visits and oral corticosteroid usage. The elderly asthmatic is particularly vulnerable and needs a shared decision-making to improve adherence. To improve patient adherence in the older asthmatic, clinicians need to consider a variety of factors and implement strategies directly targeting underlying issues that may be specific to the older patient. Strategies will be discussed, including customizing and simplifying learning and intervention regimes, identifying barriers to adherence and addressing them, ensuring patient support structures are in place and improving self-efficacy and health literacy through shared decision-making.
Moderators: Ray S. Davis, MD, FACAAI
1:00 pm
Welcome and Introductions
Ray S. Davis, MD, FACAAI
Post-PBL Interactive Discussion: Better Adherence through Shared Decision Making
Allan T. Luskin, MD, FACAAI
Andrew Weinstein, MD, FACAAI
|
|
Speaker:
Ray S. Davis, MD, FACAAI
Speaker:
Allan T. Luskin, MD, FACAAI
Speaker:
Andrew Weinstein, MD, FACAAI
|
Asthma and Respiratory / Sleep Disorders
|
Problem-Based Learning
|
Recurrent Infections With Normal or Near-normal Immunoglobulins: Now What?
ARS MOC/CME
Clinicians are often presented with patients complaining of recurrent infections; however, basic workup including serum immunoglobulins and specific antibodies may fail to demonstrate evidence of any immune deficiency. This clinical conundrum will review the presentation of these causes and the diagnostic workup. Treatment may include supportive therapies, and this clinical conundrum will review treatment options.
Moderators: Sami L. Bahna, MD, DrPh, FACAAI
1:00 pm
Welcome and Introductions
Sami L. Bahna, MD, DrPh, FACAAI
1:05 pm
When Does the Infection History Support the Diagnosis of an Immune Deficiency?
Elena E. Perez, MD
1:30 pm
Beyond Hypogammaglobulinemia: Additional Workup
Lisa R. Forbes, MD
1:55 pm
Evidence-based Management Strategies
Ivan Chinn, MD
2:20 pm
Questions and Discussion
|
|
Moderator:
Sami L. Bahna, MD, DrPH, FACAAI
Speaker:
Elena E. Perez, MD
Speaker:
Lisa R. Forbes, MD
Speaker:
Ivan Chinn, MD
|
Clinical Immunology and Autoimmune and Biologicals
|
Clinical Conundrum
|
WAO World Allergy Forum: New Frontiers in Atopic Dermatitis
New discoveries in atopic dermatitis are advancing our understanding of the underlying causes of this complex disease, as well as its role in allergic disease. New therapies give clinicians a wider range of treatment options to target specific manifestations of the disease and implement possible prevention strategies. This symposium will report on what we are learning from the new frontier of atopic dermatitis toward optimal care of the patient.
Moderators: Todd A. Mahr, MD, FACAAI, and Ignacio J. Ansotegui, MD, PhD
1:00 pm
Welcome and Introductions
Todd A. Mahr, MD, FACAAI
Ignacio J. Ansotegui, MD, PhD
1:05 pm
The Many Faces of Atopic Dermatitis
Motohiro Ebisawa, MD, PhD
1:30 pm
Novel Treatments in Atopic Dermatitis: Biologicals and Small Molecules
Mario A. Sánchez-Borges, MD
1:55 pm
International Classification of Diseases (ICD-11) and Evaluation of Quality of Life in Skin Conditions
Luciana K. Tanno, MD, PhD
2:20 pm
Questions and Discussion
|
|
Moderator:
Todd A. Mahr, MD, FACAAI
Moderator:
Ignacio J. Ansotegui, MD, PhD
Speaker:
Motohiro Ebisawa, MD, PhD
Speaker:
Mario A. Sanchez-Borges, MD
Speaker:
Luciana K. Tanno, MD, PhD
|
Dermatology
|
Symposium
|
2:30 PM - 3:00 PM
|
Refreshment Break
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. |
|
|
|
|
3:00 PM - 4:30 PM
|
Oral Abstracts Session 2A: Food Allergy
Moderators: Michael Pistiner, MD, MMSc, FACAAI, and Marissa Shams, MD, FACAAI
1:00 pm
Welcome and Introductions
Michael Pistiner, MD, MMSc, FACAAI
Marissa Shams, MD, FACAAI
3:00 pm – Clemens von Pirquet Award – First Place
A301 – Understanding the Psychosocial Impact of Food Protein-induced Enterocolitis Syndrome (FPIES)
Michelle C. Maciag, MD
3:15 pm
A302 – Utilization of Quality Improvement Methodology to Facilitate Early Peanut Introduction for At-risk Infants
Monica T. Kraft, MD
3:30 pm
A303 – Review of 122 Consecutive Oral Food Challenges to Walnut
Mary G. Baker, MD
3:45 pm
A304 – Food Allergy Resolution and Subsequent Introduction Among Black and White Children in the FORWARD Study
Adam Robinson, BS
4:00 pm
A305 – Differences in Food Allergy Knowledge Between Black and White Parents in the FORWARD Study
Jialing Jiang, BA
4:15 pm
A306 – Maternal Diet Diversity During Pregnancy and Eczema and Food Allergy in Offspring: Healthy Start Study
Carina Venter, PhD, RD
|
|
Moderator:
Michael Pistiner, MD MMSc
Moderator:
Marissa R. Shams, MD
Presenting Author:
Michelle Maciag, MD
Presenting Author:
Monica Townsend Kraft, MD
Presenting Author:
Mary Grace Baker, MD
Presenting Author:
Adam Robinson
Presenting Author:
Jialing Jiang, BA
Presenting Author:
Carina Venter, PhD, RD
|
|
Oral Abstract
|
Oral Abstracts Session 2B: Asthma, Other Lower Airway Disorders
Moderators: Myron Zitt, MD, FACAAI, and Jared Darveaux, MD
1:00 pm
Welcome and Introductions
Myron Zitt, MD, FACAAI
Jared Darveaux, MD
3:00 pm
A203 – Visual Recognition of Asthma Medications in Inner City Asthma Children and Caregivers
Mansi Kothari, MD, MBBS
3:15 pm
A204 – Stay On Therapy! Monoclonal Antibody Treatment Does Not Impact Methacholine Challenge Test Results
Maritza Rivera-Valenzuela
3:30 pm
A205 – Sex Dimorphism in the Gene Expression of Airway Epithelial Cells From Asthmatics
Sergio E. Chiarella, MD
3:45 pm
A206 – BMI Trajectory In Childhood Is Associated With Asthma at Young Adulthood Mediated by DNA Methylation
Rutu Patel, MPH, MBBS
4:00 pm
A207 – Assessing Knowledge of Asthma Management Among Internal Medicine Residents
Abigail Finley, MD, MPH
4:15 pm
A208 – Association Between Patients’ Perception of Their Asthma Control and the Symptomatic Burden of Asthma
Mark P. Small, BSc
|
|
Moderator:
Myron J. Zitt, MD, FACAAI
Moderator:
Jared Darveaux, MD
Presenting Author:
Mansi Kothari, MD, MBBS
Presenting Author:
Maritza Rivera-Valenzuela
Presenting Author:
Sergio Chiarella, MD
Presenting Author:
Rutu Patel, MPH, MBBS
Presenting Author:
Abigail Nix Finley, MD, MPH
Presenting Author:
Mark Peter Small, BSc
|
|
Oral Abstract
|
Oral Abstracts Session 2C: Other, Rhinitis, Other Upper Airway Disorders, Skin Disorders
Moderators: Desiree Larenas - Linnemann, MD and Brittanie Neaves, MD
1:00 pm
Welcome and Introductions
Desiree Larenas-Linnemann, MD and Brittanie Neaves, MD
3:00 pm – Clemens von Pirquet Award – Second Place
A352 – Is It Time to Rethink the Allergy Training Requirements for Pediatric Residents?
Peter Capucilli, MD
3:15 pm
A353 – Geographical Distribution of Allergy/Immunology Providers in the United States Is Influenced by Median Income
Di Sun, MD, MPH
3:30 pm
A354 – Healthcare Utilization in Relation to Sensitization Against HDM Pre/post a Housing Intervention in Malmö, Sweden
Jens C. Richter
3:45 pm
A355 – Impact of the Penicillin Allergy Label on Time to First Antibiotic Dose in Septic Patients
David Frankel, MD
4:00 pm
A450 – Increased Platelet and Eosinophil Numbers Are Associated With Alcohol Hypersensitivity in Chronic Rhinosinusitis
Margaret Kim, MD
4:15 pm
A500 – Association Between Maternal Diet Diversity and Infant Microbial Abundance: IOW 3rd Generation Cohort
Syed H. Arshad, MBBS, DM
|
|
Moderator:
Desiree E. Larenas-Linnemann, MD
Moderator:
Brittanie I. Neaves, MD
Presenting Author:
Peter Capucilli, MD
Presenting Author:
Di Sun, MD, MPH
Presenting Author:
Jens C. Richter
Presenting Author:
David Frankel
Presenting Author:
Margaret Kim, MD
Presenting Author:
Syed H. Arshad, MBBS, DM
|
|
Oral Abstract
|
How to Implement a Penicillin Allergy Program in Your Community
It has been well established that 10% of the general population reports having a penicillin allergy, but 90% of those individuals are not truly allergic. Allergists can be exceptionally useful in the education surrounding penicillin allergy and assessment through skin testing and oral challenges. This symposium will discuss how allergists can serve as experts and advocates in their community, regardless of their practice setting, in the communication and development of a penicillin allergy reconciliation program.
Moderators: David R. Stukus, MD, FACAAI, and Allison Ramsey, MD, FACAAI
3:00 pm
Welcome and Introductions
David R. Stukus, MD, FACAAI
Allison Ramsey, MD, FACAAI
3:05 pm
How to Effectively Educate Patients, the General Public, and Our Colleagues About Penicillin Allergy
David R. Stukus, MD, FACAAI
3:30 pm
Utilization of Algorithms to Assess Patients Across the Spectrum, From Inpatient Hospitalization to the Outpatient Setting
Kimberly G. Blumenthal, MD, MSc
3:55 pm
We Need to Own This: The Role of the Allergist
David A. Khan, MD, FACAAI
4:20 pm
Questions and Discussion
|
|
Moderator:
David R. Stukus, MD, FACAAI
Speaker:
David R. Stukus, MD, FACAAI
Speaker:
David A. Khan, MD, FACAAI
Moderator:
Allison C. Ramsey, MD, FACAAI
Speaker:
Kimberly G. Blumenthal, MD, MSc
|
Population Health and Infectious Diseases / International Travel
|
Symposium
|
PBL – A Child With Asthma and Food Allergy That Needs Proper Coding: Codeman and Doctor Document Strike Again
Limit 40. Seats available on first-come, first-served basis.
Following a real-time assessment of the audience discussion of the PBL case, Dr. Meadows, Dr. Gross and the audience will interactively discuss proper coding and documentation for the patient.
Moderator: Don A. Bukstein, MD, FACAAI
3:00 pm
Welcome and Introductions
Don A. Bukstein, MD, FACAAI
Post-PBL Interactive Discussion
Gary N. Gross, MD, FACAAI
J. Allen Meadows, MD, FACAAI
|
|
Moderator:
Don A. Bukstein, MD, FACAAI
Speaker:
Don A. Bukstein, MD, FACAAI
Speaker:
Gary N. Gross, MD, FACAAI
Speaker:
J. Allen Meadows, MD, FACAAI
|
Practice Management / Professional Issues
|
Problem-Based Learning
|
Telemedicine for the Allergist
MOC/CME
The technology involved in telemedicine, direct-to-consumer platforms and case examples of actual technology will be discussed and reviewed. This expert presentation will spark your interest in exploring the future of telemedicine.
Moderators: Jay M. Portnoy, MD, FACAAI, and Justin C. Greiwe, MD, FACAAI
3:00 pm
Welcome and Introductions
Jay M. Portnoy, MD, FACAAI
Justin C. Greiwe, MD, FACAAI
3:05 pm
How to Get Started in Telemedicine
Jay M. Portnoy, MD, FACAAI
3:25 pm
Direct-to-consumer Telemedicine
Tania Elliott, MD, FACAAI
3:45 pm
Facilitated Telemedicine as Virtual Visits
Jennifer Shih, MD
4:05 pm
The Future of Telemedicine for Allergy
David M. Lang, MD, FACAAI
4:20 pm
Questions and Discussion
|
|
Moderator:
Jay M. Portnoy, MD, FACAAI
Moderator:
Justin C. Greiwe, MD, FACAAI
Speaker:
Jay M. Portnoy, MD, FACAAI
Speaker:
Jennifer Shih, MD
Speaker:
Tania Elliott, MD, FACAAI
Speaker:
David M. Lang, MD, FACAAI
|
Practice Management / Professional Issues
|
Symposium
|
4:45 PM - 6:30 PM
|
Town Hall Meeting presented by the House of Delegates and Annual Business Meeting
Town Hall Meeting hosted by House of Delegates
4:45 – 5:30 pm
Not For Credit
Beer, wine and cheese reception. All meeting attendees welcome!
4:45 pm
Welcome and Introductions
Travis Miller, MD, FACAAI, Speaker of the ACAAI House of Delegates
4:50 pm
Medicare for All
Susan Rudd Bailey, MD, FACAAI, President-elect of the AMA
5:05 pm
Health Care Disparities
Bill Finerfrock, President, Capitol Associates, Inc.
5:20 pm
Questions and Discussion
5:30 pm
ACAAI Annual Business Meeting Commences
Annual Business Meeting
5:30 – 6:30 pm
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
The College invites all members to attend.
Call to Order and Approval of 2018 Minutes & Standing Rules, State of the College
Todd A. Mahr, MD, FACAAI, President
Historian’s Report
Joseph A. Bellanti, MD, FACAAI, Historian
Presentation of New Fellows, Distinguished and International Distinguished Fellows, Distinguished Service, Woman in Allergy, Special Recognition and EMD Awards
Todd A. Mahr, MD, FACAAI
Foundation Report and Young Faculty Support Awards
Richard W. Weber, MD, FACAAI, Foundation President
Alliance Report and Clemens von Pirquet Awards
Mrs. Patricia Wedner, Alliance President
Bylaws Committee Report
Gregory W. Bensch, MD, FACAAI, Bylaws Committee Chair
Recognition of Outgoing Regents
Todd A. Mahr, MD, FACAAI
Nominating Council Report and Election of Officers
Bryan L. Martin, DO, FACAAI, Nominating Council Chair
Installation of New President and President’s Acceptance
Todd A. Mahr, MD, FACAAI
J. Allen Meadows, MD, FACAAI, President 2019-2020
Presentation to Outgoing President and New Business
J. Allen Meadows, MD, FACAAI |
|
Moderator:
Travis A. Miller, MD, FACAAI
Speaker:
Susan R. Bailey, MD, FACAAI
|
|
|
7:00 PM - 9:00 PM
|
Non-CME Corporate Forum: Marching Forward in Atopic Dermatitis: Digging Deep on Shared Decision Making
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
Not For Credit
Presented by:
Peter A. Lio, MD
Anne Marie Singh, MD
In this Interactive Exchange™ dinner program, faculty will review the pathophysiology of atopic dermatitis, and discuss clinical characteristics, and comorbid conditions. Experts will describe appropriate use of systemic treatment options, including biologic therapy. Attendees of this program will gain a fresh perspective on management strategies for patients with moderate-to-severe disease.
Also, visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.at Booth #313. |
|
|
|
|